Abstract:Structure-based drug design (SBDD) utilizes the three-dimensional geometry of proteins to identify potential drug candidates. Traditional methods, grounded in physicochemical modeling and informed by domain expertise, are resource-intensive. Recent developments in geometric deep learning, focusing on the integration and processing of 3D geometric data, coupled with the availability of accurate protein 3D structure predictions from tools like AlphaFold, have greatly advanced the field of structure-based drug design. This paper systematically reviews the current state of geometric deep learning in SBDD. We first outline foundational tasks in SBDD, detail prevalent 3D protein representations, and highlight representative predictive and generative models. We then offer in-depth reviews of each key task, including binding site prediction, binding pose generation, \emph{de novo} molecule generation, linker design, and binding affinity prediction. We provide formal problem definitions and outline each task's representative methods, datasets, evaluation metrics, and performance benchmarks. Finally, we summarize the current challenges and future opportunities: current challenges in SBDD include oversimplified problem formulations, inadequate out-of-distribution generalization, a lack of reliable evaluation metrics and large-scale benchmarks, and the need for experimental verification and enhanced model understanding; opportunities include leveraging multimodal datasets, integrating domain knowledge, building comprehensive benchmarks, designing criteria based on clinical endpoints, and developing foundation models that broaden the range of design tasks. We also curate \url{<a class="link-external link-https" href="https://github.com/zaixizhang/Awesome-SBDD" rel="external noopener nofollow">this https URL</a>}, reflecting ongoing contributions and new datasets in SBDD.

Geometric deep learning methods and applications in 3D structure-based drug design

Structure-based drug design with geometric deep learning

A Systematic Survey in Geometric Deep Learning for Structure-based Drug Design

Geometric Deep Learning for Drug Discovery

Advances in Deep Learning-Based 3D Molecular Generative Models

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

Deep Learning in Structure-Based Drug Design

Geometric Deep Learning for Structure-Based Ligand Design

Geometric Deep Learning on Molecular Representations

Learning to design drug-like molecules in three-dimensional space using deep generative models

RELATION: A Deep Generative Model for Structure-Based De Novo Drug Design

Learning on topological surface and geometric structure for 3D molecular generation

A geometric deep learning framework for drug repositioning over heterogeneous information networks

Application advances of deep learning methods for de novo drug design and molecular dynamics simulation

Structure-based <i>de novo</i> drug design using 3D deep generative models

Structure-based drug discovery with deep learning

Recent Progress of Deep Learning in Drug Discovery

Advances and Challenges in De Novo Drug Design Using Three-Dimensional Deep Generative Models

Synthesis-driven design of 3D molecules for structure-based drug discovery using geometric transformers

Geom-SAC: Geometric Multi-Discrete Soft Actor Critic With Applications in De Novo Drug Design

Geometric Deep Learning: Going beyond Euclidean data